Cases & Deals

Abbott invests in AuraSense Therapeutics

Clients Abbott Laboratories

Jones Day advised Abbott Laboratories, a leading global health care company, in connection with its purchase of Series B Convertible Preferred Stock in a private placement by AuraSense Therapeutics, LLC, a biopharmaceutical company commercializing spherical nucleic acid (SNA™) constructs as gene regulation- and chemo-therapeutics for a variety of diseases.